| Page 1296 | Kisaco Research
 

Ali Mostashari

CEO
LifeNome

Ali Mostashari, Ph.D. (MIT) is a co-founder of LifeNome (https://www.lifenome.com), a Precision (biology-personalized) Nutrition and Health AI company headquartered in New York City. He is in the top 20 cited scholars in the world in complexity science.

Ali Mostashari

CEO
LifeNome

Ali Mostashari

CEO
LifeNome

Ali Mostashari, Ph.D. (MIT) is a co-founder of LifeNome (https://www.lifenome.com), a Precision (biology-personalized) Nutrition and Health AI company headquartered in New York City. He is in the top 20 cited scholars in the world in complexity science. Concurrently he serves as a Member of the Global Futures Council of the World Economic Forum. LifeNome leverages biological, physiological, and behavioral data to hyper-personalize needs assessments and health and wellness interventions in the preventative health, nutrition, fitness, insurance and personal care/beauty industries.

 

Being Persuasive via Video: Best Practice in Video Conferencing in Europe and US

Craig Svobod, Global Head of IP, Alvotech

Andras Kupecz, Partner, Pinsent Masons (NED)

Being Persuasive via Video: Best Practice in Video Conferencing in Europe and US

Being Persuasive via Video: Best Practice in Video Conferencing in Europe and US

Craig Svobod, Global Head of IP, Alvotech

Andras Kupecz, Partner, Pinsent Masons (NED)

 

Address IP Challenges in the Pharmaceutical AI World

Jason Rice, Patent Attorney, GSK

Matt Hervey, Head of Artificial Intelligence Law, Gowling WLG (UK)

Pete Sadler, Partner, Reddie & Grose (UK)

Address IP Challenges in the Pharmaceutical AI World

Address IP Challenges in the Pharmaceutical AI World

Jason Rice, Patent Attorney, GSK

Matt Hervey, Head of Artificial Intelligence Law, Gowling WLG (UK)

Pete Sadler, Partner, Reddie & Grose (UK)

2022 Sample Attendee List
 

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Brian Coggio, Attorney, Fish & Richardson (USA)

Adrian Chew, Senior Associate, Bristows LLP (UK)

Daan De Laange, Partner, Brinkhof (NED)

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Eli Lilly vs Fresenius Kabi: A Continued Balancing Act for Doctrine of Equivalence?

Brian Coggio, Attorney, Fish & Richardson (USA)

Adrian Chew, Senior Associate, Bristows LLP (UK)

Daan De Laange, Partner, Brinkhof (NED)

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

 

Daniel Lim

Partner
Kirkland & Ellis

Daniel Lim

Partner
Kirkland & Ellis

Daniel Lim

Partner
Kirkland & Ellis
 

Strategic Consideration for Patent Portfolio Litigation

Mark van Gardingen, Partner, Brinkhof

Kristin Cooklin, Head of Intellectual Property, Zentiva

Dr Inga- Marlene Pietsch, Principal Associate, Gowling WLG (GBR)

Strategic Consideration for Patent Portfolio Litigation

Strategic Consideration for Patent Portfolio Litigation

Mark van Gardingen, Partner, Brinkhof

Kristin Cooklin, Head of Intellectual Property, Zentiva

Dr Inga- Marlene Pietsch, Principal Associate, Gowling WLG (GBR)

 

Discovering New Frontier for Second Medical Use Patent

Nitika Gupta Fiorella, Principal, Fish & Richardson (USA)

Tjibbe Douma, Partner, Bird & Bird (NED)

Tessa M. Malamud-Cohen, Director, Patents, Global Intellectual Property, Ferring Pharmaceuticals

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

Discovering New Frontier for Second Medical Use Patent

Discovering New Frontier for Second Medical Use Patent

Nitika Gupta Fiorella, Principal, Fish & Richardson (USA)

Tjibbe Douma, Partner, Bird & Bird (NED)

Tessa M. Malamud-Cohen, Director, Patents, Global Intellectual Property, Ferring Pharmaceuticals

Ewan Nettleton, Principal IP Counsel, Oncology Litigation, Novartis Pharma AG

 

Establishing a Successful Cross Border Relief Strategy

Cecile Teles, Head of Patent Attorney, Zentiva

Ricardo Dijkstra, Partner, Vondst (NED)

Establishing a Successful Cross Border Relief Strategy

Establishing a Successful Cross Border Relief Strategy

Cecile Teles, Head of Patent Attorney, Zentiva

Ricardo Dijkstra, Partner, Vondst (NED)

 

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Rieke Kaup, DG Competition, European Commission

Sara Burghart, Lead IP Litigation Counsel – Global Litigation & Launch, Sandoz

Corinna Sundermann, Senior Vice President Intellectual Property, Fresenius Kabi Deutschland

Moderator: Stephan Neuhaus, Partner, Allen & Overy (DEU)

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Divisional Patents Strategy: Safeguarding Innovation or Anti Competitive?

Rieke Kaup, DG Competition, European Commission

Sara Burghart, Lead IP Litigation Counsel – Global Litigation & Launch, Sandoz

Corinna Sundermann, Senior Vice President Intellectual Property, Fresenius Kabi Deutschland

Moderator: Stephan Neuhaus, Partner, Allen & Overy (DEU)